Literature DB >> 7472559

Role of N-methyl-D-aspartate receptor in acute spinal cord injury.

M Yanase1, T Sakou, T Fukuda.   

Abstract

To clarify the role of N-methyl-D-aspartate (NMDA) receptors in acute spinal cord injury, changes in the intraspinal microcirculation after acute spinal cord injury in rabbits were examined. Systemic administration of MK-801, an NMDA receptor antagonist, at a dose of 5 mg/kg, significantly improved motor recovery after injury and significantly reduced edema formation at the injured site without altering spinal cord blood flow or vascular permeability at the injured site. These findings indicate that excitatory amino acids contribute to secondary spinal cord damage, especially edema formation, mediated by NMDA receptors in the early stage after injury.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7472559     DOI: 10.3171/jns.1995.83.5.0884

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  6 in total

1.  Neuroprotective effects of N-methyl-D-aspartate receptor antagonist on aspartate induced neurotoxicity in the spinal cord in vivo.

Authors:  Yasunori Cho; Toshihiko Ueda; Atsuo Mori; Hideyuki Shimizu; Ryohei Yozu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-10

2.  Pathology dynamics predict spinal cord injury therapeutic success.

Authors:  Cassie S Mitchell; Robert H Lee
Journal:  J Neurotrauma       Date:  2008-12       Impact factor: 5.269

3.  The effects of chronic alpha-tocopherol administration on lipid peroxidation in an experimental model of acute spinal cord injury.

Authors:  M Bozbuğa; N Izgi; A Canbolat
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

4.  Estrogen attenuates glutamate-induced cell death by inhibiting Ca2+ influx through L-type voltage-gated Ca2+ channels.

Authors:  Eric A Sribnick; Angelo M Del Re; Swapan K Ray; John J Woodward; Naren L Banik
Journal:  Brain Res       Date:  2009-04-21       Impact factor: 3.252

5.  Spatiotemporal expression of Dexras1 after spinal cord transection in rats.

Authors:  Xin Li; Chun Cheng; Min Fei; Shangfeng Gao; Shuqiong Niu; Mengling Chen; Yonghua Liu; Zhiqin Guo; Haibo Wang; Jian Zhao; Xiaowei Yu; Aiguo Shen
Journal:  Cell Mol Neurobiol       Date:  2008-01-25       Impact factor: 5.046

6.  Uric acid released from poly(ε-caprolactone) fibers as a treatment platform for spinal cord injury.

Authors:  Nisha K Singh; Salman Khaliq; Mann Patel; N'Dea Wheeler; Sudeepti Vedula; Joseph W Freeman; Bonnie L Firestein
Journal:  J Tissue Eng Regen Med       Date:  2020-11-21       Impact factor: 3.963

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.